CEPHEID
Registration 3004530258FEI 3004530258Sunnyvale, CA
Owner/operator: CEPHEID
- Develop Specifications But Do Not Manufacture At This Facility
- Manufacture Device in the United States for Export Only
- Manufacture Medical Device
Renewal due by December 31, 2026
Registered through 2026. Renew between October 1 and December 31, 2026, to stay registered for 2027.
90days left in the window
The 2026 window
- Oct 1Window opens91 days left
- Nov 3Where you stand58 days left
- Dec 1Our pay-by date30 days left
- Dec 15Two weeks left16 days left
- Dec 23Holiday week8 days left
- Dec 29Two days left2 days left
- Dec 31Window closes0 days left
- FDA fee, FY2027
- $13,785
- Our pay-by suggestion
- Dec 1
- Listed devices
- 103
- Added, last 12 months
- 3
FDA sets who pays the fee and who may qualify for a waiver; its fee page says so. The fee is paid only on FDA’s own fee site. Never through us. FDA’s fee page
The steps, in order
Pay FDA's annual feeYou
Order and pay the FY2027 establishment fee on FDA's Device Facility User Fee site. FDA emails you a PIN when you order.
FDA: registration and listing payment processWait for the payment confirmation numberYou
FDA emails a Payment Confirmation Number (PCN) once the payment processes, which FDA says typically takes several days. That is why we suggest paying by December 1.
FDA: registration and listing payment processRenew the registration in FDA's systemYou
Sign in to FDA's Unified Registration and Listing System (FURLS), complete the annual registration and apply your PIN and PCN. FDA does not count the registration as complete until both are applied.
FDA: device registration and listingReview every listingYou
In the same window, review each listing on file and report any changes, deletions and new listings. Your Listing Review Sheet puts every listing on one page.
FDA: device registration and listing
Every listed device 103
| Code | Device | Class | Regulation | Premarket |
|---|---|---|---|---|
| OWD | Xpert Breast Cancer STRAT4Somatic Gene Mutation Detection System | Class 3 | — | — |
| NAH | Xpert Bladder Cancer DetectionSystem, Test, Tumor Marker, For Detection Of Bladder Cancer | Class 3 | — | — |
| OAI | XPERT EVAssay, Enterovirus Nucleic Acid | Class 2 | 21 CFR 866.3225 | DEN070004 |
| OYX | Xpert BCR-ABL UltraBcr/Abl1 Monitoring Test | Class 2 | 21 CFR 866.6060 | K190076 |
| OYX | Xpert BCR-ABL UltraBcr/Abl1 Monitoring Test | Class 2 | 21 CFR 866.6060 | — |
| QDC | Xpert NPM1 MutationDna-Based Test For Minimal Residual Disease For Hematologic Malignancies | Class 2 | 21 CFR 866.6100 | — |
| LSL | Xpert CT/NGDna-Reagents, Neisseria | Class 2 | 21 CFR 866.3390 | K190441 |
| LSL | Xpert CT/NGDna-Reagents, Neisseria | Class 2 | 21 CFR 866.3390 | — |
| PCH | Xpert GI PanelGastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay SystemAdded Jan 28, 2026 | Class 2 | 21 CFR 866.3990 | K251721 |
| PCH | Xpert NorovirusGastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System | Class 2 | 21 CFR 866.3990 | K142501 |
| PGX | Xpert Xpress Step AGroups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System | Class 2 | 21 CFR 866.2680 | — |
| PGX | Xpert Xpress Strep AGroups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System | Class 2 | 21 CFR 866.2680 | K172126 |
and 91 more on your full dossier
What changed
- Jan 28, 2026Listing added: PCH — Xpert GI Panel (K251721)
- Aug 18, 2026Listing added: QVR — Xpert® Hemorrhagic Fever (K261362)
- Aug 18, 2026Listing added: OOI — Xpert® Hemorrhagic Fever (K261362)